|
|
|
Company
Name |
Short
Summary |
| Actium BioSystems |
Actium BioSystems is focused on the research and development of nanoparticle based treatments for cancer. |
| Amgen |
Amgen
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology. |
| Array BioPharma |
Array BioPharma is focused on small molecule drugs to treat cancer and inflammatory diseases. |
| Bolder Biotechnology |
Bolder Biotechnology is focused on using site-specific pegylation and immunofusion protein technology to produce proteins with a greater half-life. |
| Covidien |
Covidien is focused on the devevlopment and commercialization of clinical and home healthcare products. |
| Gilead
Sciences |
Gilead
has a broad-based focus in infectious disease,
including antivirals, antifungals and antibiotics,
as well as a specialized focus in oncology. |
| Hospira |
Hospira is focused on commercialization of generic acute-care and oncology injectables and integrated infusion therapy and medication management solutions. Hospira also provides contract manufacturing services to pharmaceutical and biotechnology companies for injectable products. |
| Martek
Biosciences |
Martek
Biosciences develops, manufactures and sells products
derived from algae. |
| OSI
Pharmaceuticals |
OSI's
research programs are focused in the areas of
cancer therapeutics and diagnostics, cosmeceuticals,
and anti-infectives. |
| Quark Pharmaceuticals |
Quark Pharmaceuticals is focused on the discovery, research, and development of RNAi-based therapeutics. |
| SomaLogic |
SomaLogic is focused on the research and development of protein based diagnostic products for a variety of diseases. |
| Tapestry
Pharmaceuticals |
Tapestry
Pharmaceuticals is involved in the development of
drugs to treat cancer. |
